Programmable Lipid Nanoparticle Delivery via Corona Protein Engineering
Invention type: Technology
/
Case number: #25165
Researchers
Departments: McGovern Institute for Brain Research, Brain and Cognitive Sciences
Technology Areas: Biotechnology: Synthetic Biology / Chemicals & Materials: Nanotechnology & Nanomaterials / Drug Delivery: Microparticles & Nanoparticles / Therapeutics: Nucleic Acids
Impact Areas: Healthy Living
-
programmable lipid nanoparticle delivery via corona proteinengineering
United States of America | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.